The treatment of postprandial hypotension in autonomic failure with 3,4- dl-threo-dihydroxyphenylserine

Roy Freeman*, James Young, Lewis Landsberg, Lewis Lipsitz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Postprandial hypotension occurs commonly in patients with autonomic failure and may be due to attenuation of the normal sympathetic nervous system activation in response to meal ingestion. In a randomized, double- blind, placebo-controlled study, we investigated the therapeutic effect of the norepinephrine precursor 3,4-DL-threodihydroxyphenylserine (DL-DOPS) on this condition. We measured blood pressure, heart rate, forearm vascular resistance, and plasma DL-DOPS and norepinephrine in 11 patients with autonomic failure. DL-DOPS attenuated the postprandial fall in blood pressure. This was associated with an increase in plasma norepinephrine and forearm vascular resistance. DL-DOPS therapy did not change the postprandial increase in heart rate. There was a trend toward increased supine hypertension associated with DL-DOPS treatment. This study shows that DL- DOPS is a promising treatment for postprandial hypotension and provides support for the hypothesis that postprandial hypotension is, at least in part, due to decreased activation of the sympathetic nervous system.

Original languageEnglish (US)
Pages (from-to)1414-1420
Number of pages7
Issue number6
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'The treatment of postprandial hypotension in autonomic failure with 3,4- dl-threo-dihydroxyphenylserine'. Together they form a unique fingerprint.

Cite this